Learn About Robotics in General Surgery

OSUWexnerbloglogo2014 Learn about Robotics in General Surgery. In the past on MedNet, we’ve heard about how robotics have been applied to surgical specialties. On this CME webcast, we’re going to hear about how the surgical robot is being used in general surgical procedures. Our guests today are both robotic experts. Dr. Jennifer Schwartz is an Assistant Professor of Surgery and specializes in minimally invasive surgery. And Dr. Michael Meara is also an Assistant Professor of Surgery and specializes in therapeutic endoscopy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE applications of robotic surgery as it relates to inguinal hernia repair and cholecystectomy; DISCUSS importance of including robotic surgery training as it relates to resident and fellowship training; DISCUSS the role of robotics in foregut, bariatric, and ventral hernia repair; and EXPLAIN potential advantages and disadvantages of robotics in general surgery.

You’ll also learn about the following:

  • What the surgical robot actually does
  • General surgical applications of robotics
  • Starting a robotic program in your hospital
  • Equipment costs
  • Insurance coverage
  • Credentialing
  • How to select a surgeon to do your inguinal herniorrhaphy
  • Future applications of robotics in general surgery
  • Converting robotic to open surgical procedures
  • Patient variables in technique selection

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Latest Webcast Educates Physicians on Mitral Regurgitation Transcatheter Repair

OSUWexnerbloglogo2014 Latest Webcast Educates Physicians on Mitral Regurgitation Transcatheter Repair. On this CME webcast, we have a great program for you. First, to tell us about the new procedure of repairing mitral regurgitation using cardiac catheterization techniques is interventional cardiologist and Associate Professor of Internal Medicine at the Ohio State University, Dr. Dean Boudoulas. And then to give us insight on differences in outcomes between transcatheter repair versus surgical replacement, Professor and Director of the Division of Cardiac Surgery at Ohio State, Dr. Juan Crestanello.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN etiologies of mitral regurgitation; LEARN management of mitral regurgitation using transcatheter mitral valve repair/ mitraclip device; DESCRIBE the benefits of mitral valve repair over replacement; and DESCRIBE the natural history of mitral regurgitation.

You’ll also learn about the following:

  • Catheter-based techniques to repair mitral regurgitation
  • Patient selection for transcatheter mitral valve repair
  • The future of transcatheter mitral valve repair
  • Minimally invasive techniques for mitral stenosis
  • Timing of either repair or replacement in mitral regurgitation
  • Medical management of mitral regurgitation
  • The effect of atrial fibrillation in clinical decision making

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Discover Systemic Lupus Erythematosus on CME Webcast

OSUWexnerbloglogo2014 Discover Systemic Lupus Erythematosus on CME Webcast. There’s a lot of misconceptions about lupus, for example, not every patient with a positive ANA has lupus. On this CME webcast, we’re going to help you sort out your patients with lupus, how you know if a patient really has it, how it can affect different organ systems, and how you treat it. Here with our moderator, in the studio, are two of Ohio State’s experts in systemic lupus erythematosus. Dr. Alexa Meara is a Clinical Instructor in the Division of Rheumatology and Immunology. And Dr. Wael Jarjour is an Associate Professor of Internal Medicine and the Director of the Division of Rheumatology and Immunology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE how to Diagnosis SLE; RECOGNIZE common signs and symptoms of SLE; UNDERSTAND when to refer to a specialist; RECOGNIZE comorbidities and treatments of SLE and the importance of a PCP for patients with SLE.

You’ll also learn about the following:

  • Common signs and symptoms of SLE
  • Whether SLE is curable
  • When to refer to a specialist
  • Future treatments for lupus
  • Lupus flares
  • Prognosis of SLE
  • SLE and pregnancy
  • Children with lupus
  • Discoid/cutaneous lupus

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Discusses New Drugs for Heart Failure

OSUWexnerbloglogo2014 Webcast Discusses New Drugs for Heart Failure. If you are at all affiliated with a hospital, any hospital, then getting the management of heart failure right the first time is not only good medicine, it’s good business. Currently, the Center for Medicare and Medicaid Services penalizes hospitals for excessively high 30-day readmissions for patients with heart failure. This year, 76% of U.S. hospitals will pay a penalty for excessively high readmissions for a total of $428 million dollars. So we are more incentivized than ever before to be at the top of our game for heart failure treatment. In the studio, with moderator Dr. Jim Allen, to update us on heart failure treatment are two of Ohio State University’s top heart failure specialists. First, to tell us about new medications for heart failure, cardiologist and Assistant Professor of Internal Medicine, Dr. Brent Lampert. And then to tell us about new devices used to treat heart failure, is Assistant Professor from the Division of Cardiovascular Medicine, Dr. Rami Kahwash.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Provide an OVERVIEW of the primary prevention strategies of sudden cardiac death in chronic systolic heart failure; and DESCRIBE the role of new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

You’ll also learn about the following:

  • New medications for heart failure
  • New devices for heart failure
  • Future Apps for Cardiac hemodynamic monitoring
  • Ivabradine and sacubitril-valsartan in diastolic heart failure

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn More About Robotic Surgery

OSUWexnerbloglogo2014 Learn more about Robotic Surgery during our latest webcast.  In 1999, surgeons at the Ohio State University were the first to perform a robotically assisted heart bypass surgery.  Today, robotic surgery is used in almost every surgical discipline. Every year, robotic techniques keep improving with greater precision, more miniaturization, smaller incisions, and faster healing time.  It’s an exciting time because we are truly in the midst of a revolution in surgery.  Joining Dr. Jim Allen in the studio today to tell us more about robotic surgery is Professor of Surgery and the Chief of the Division of Thoracic Surgery at Ohio State University, Dr. Patrick Ross.  Presenting with him we have OSU surgical oncologist and Associate Professor of Surgery, Dr. Carl Schmidt.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the advantages of minimally invasive thoracic surgery; RECOGNIZE the options for minimally invasive lobectomy; ILLUSTRATE the scope of robotic operations for thoracic cancers; and DESCRIBE the scope of robotic operations for abdominal and pelvic cancers.

You’ll also learn about the following:

  • Training for robotic surgery
  • The future of robotic surgery in surgical oncology

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.